BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27764046)

  • 21. Subacute Cortical Infarct Showing Uptake on 68Ga-PSMA PET/CT.
    Chan M; Hsiao E
    Clin Nucl Med; 2017 Feb; 42(2):110-111. PubMed ID: 27997426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intense Uptake in Amyloidosis of the Seminal Vesicles on 68Ga-PSMA PET Mimicking Locally Advanced Prostate Cancer.
    Stephens M; Kim DI; Shepherd B; Gustafson S; Thomas P
    Clin Nucl Med; 2017 Feb; 42(2):147-148. PubMed ID: 27879490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 68Ga-Prostate-Specific Membrane Antigen Uptake in a Pancreatic Neuroendocrine Tumor.
    Luong TV; Iversen P; Bouchelouche K; Arveschoug AK
    Clin Nucl Med; 2020 May; 45(5):379-382. PubMed ID: 32149792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lumbar Osteophyte Avid on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Jochumsen MR; Madsen MA; Gammelgaard L; Bouchelouche K
    Clin Nucl Med; 2018 Jun; 43(6):456-457. PubMed ID: 29538033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of
    Schwenck J; Rempp H; Reischl G; Kruck S; Stenzl A; Nikolaou K; Pfannenberg C; la Fougère C
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):92-101. PubMed ID: 27557844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary Opacities and Bronchiectasis Avid on 68Ga-PSMA PET.
    Bouchelouche K; Vendelbo MH
    Clin Nucl Med; 2017 Apr; 42(4):e216-e217. PubMed ID: 28134694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
    Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
    Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: A prospective study in Taiwan.
    Chen SH; Chang YC; Hwang TL; Chen JS; Chou WC; Hsieh CH; Yeh TS; Hsu JT; Yeh CN; Tseng JH; Chen TC; Yen TC
    J Formos Med Assoc; 2018 Jun; 117(6):480-487. PubMed ID: 28735662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Utility of 68Ga-PSMA PET/CT in Poorly Differentiated Metastatic Prostate Cancer.
    Demirkol MO; Kiremit MC; Acar O; Ucar B; Saglican Y
    Clin Nucl Med; 2017 May; 42(5):403-405. PubMed ID: 28319496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
    Meyrick DP; Asokendaran M; Skelly LA; Lenzo NP; Henderson A
    Nucl Med Commun; 2017 Nov; 38(11):956-963. PubMed ID: 28922335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer.
    Sachpekidis C; Eder M; Kopka K; Mier W; Hadaschik BA; Haberkorn U; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1288-99. PubMed ID: 26753602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
    Bhardwaj H; Stephens M; Bhatt M; Thomas PA
    Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.
    Kabasakal L; Demirci E; Nematyazar J; Akyel R; Razavi B; Ocak M; Aygun A; Obek C; Kural AR
    Nucl Med Commun; 2017 Feb; 38(2):149-155. PubMed ID: 27893589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological predictors of positive
    Aydin AM; Haberal B; Artykov M; Bilen CY; Yazici S
    Ann Nucl Med; 2019 May; 33(5):326-332. PubMed ID: 30778860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.
    Lawhn-Heath C; Flavell RR; Glastonbury C; Hope TA; Behr SC
    Clin Nucl Med; 2017 Apr; 42(4):e218-e220. PubMed ID: 28166149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 68Ga-PSMA PET/CT Detects the Location and Extent of Primary Prostate Cancer.
    Fendler WP; Schmidt DF; Wenter V; Thierfelder KM; Zach C; Stief C; Bartenstein P; Kirchner T; Gildehaus FJ; Gratzke C; Faber C
    J Nucl Med; 2016 Nov; 57(11):1720-1725. PubMed ID: 27261520
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Ceci F; Castellucci P; Graziani T; Farolfi A; Fonti C; Lodi F; Fanti S
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):31-39. PubMed ID: 30350010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity Comparison of
    Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
    Keidar Z; Gill R; Goshen E; Israel O; Davidson T; Morgulis M; Pirmisashvili N; Ben-Haim S
    Cancer Imaging; 2018 Nov; 18(1):39. PubMed ID: 30382889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.